Nomura Asset Management
AUTL icon

Nomura Asset Management’s Autolus Therapeutics AUTL Stock Holding History

Nomura Asset Management’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-384,796
Closed -$2.45M – 1507
2024
Q1 		$2.45M Buy
+384,796
New +$2.4M 0.01% 689

Other funds holding AUTL

SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nomura Asset Management's AUTL Position: Q2 2024 in Review

Nomura Asset Management sold out of Autolus Therapeutics (AUTL) in Q2 2024, closing a stake of 384,796 shares — an estimated $2.45M sold.

Nomura Asset Management first reported a position in AUTL in Q1 2024 and held it in 1 quarter. The position peaked at $2.45M in Q1 2024. 111 funds tracked by Wall St. Rank hold AUTL as of Q2 2024.

  • Nomura Asset Management reported no remaining Autolus Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Nomura Asset Management sold 384,796 Autolus Therapeutics shares in Q2 2024, an estimated $2.45M.
  • Nomura Asset Management first reported a position in Autolus Therapeutics in Q1 2024 and held it in 1 quarter.
  • Nomura Asset Management's Autolus Therapeutics position peaked at $2.45M in Q1 2024.
  • 111 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2024.

Based on Nomura Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.